AuthMind, a leader in identity observability-driven AI, has been recognized as a Representative Provider in Gartner's "Innovation Insight: Identity Visibility and Intelligence Platforms" report. The report highlights the critical need for Identity Visibility and Intelligence Platforms (IVIPs) to provide actionable insights for improving IAM configurations and enhancing security posture, especially with the growing use of AI. AuthMind's platform offers identity observability across human, non-human, and agentic AI identities, correlating real access activity to address visibility gaps.

Elevance Health Inc (ELV) has announced a quarterly dividend of $1.72 per share, with an ex-dividend date of September 10, 2026. The company has a consistent history of dividend payments since 2011, increasing its dividend annually and maintaining a low payout ratio of 0.23, indicating strong sustainability. While profitability and dividend growth rates are solid, recent EPS and EBITDA growth have underperformed some global competitors, suggesting potential moderation in future dividend increases.

Kenvue Inc. (NYSE:KVUE) announced a quarterly dividend of $0.21 per share on its common stock. The dividend is scheduled to be payable on October 2, 2026, to shareholders who are on record by September 21, 2026. This information was released in a press statement by the company's Board of Directors.

TELUS Corp (NYSE:TU) recently announced a dividend of $0.13 per share, payable on October 1, 2026, maintaining a consistent payment record since 1999. While the company boasts a strong profitability rank and a history of dividend increases, its high payout ratio of 3.42 and negative growth trends in EPS and EBITDA raise concerns about the long-term sustainability of its dividend growth. Income investors are advised to weigh the attractive yield against these fundamental headwinds and monitor future operational improvements.

UMB Financial Corp (UMBF) recently announced a $0.50 per share dividend, with an ex-dividend date of September 10, 2026, and a payment date of October 1, 2026. The company has a remarkable 42-year history of increasing its dividends, making it a dividend aristocrat, supported by a low payout ratio of 0.13 and consistent profitability. While its dividend yield of 1.21% is near a 10-year low and underperforms many competitors, its consistent growth and conservative capital management may appeal to dividend growth investors.

ResMed CEO Michael J. Farrell recently sold approximately $1.11 million worth of company shares and simultaneously exercised options to acquire common stock valued at about $730,382. These transactions, executed under a Rule 10b5-1 trading plan, resulted in the sale of 4,991 shares at a weighted average price of $222.4385 per share. Following these actions, Farrell directly holds 466,256 shares, with an additional 2,090 shares held indirectly through a family trust.

Tenable Holdings, Inc. announced its intention to offer $650 million in convertible senior notes due 2031 through a private placement, with an option for initial purchasers to buy an additional $65 million. The company plans to use the proceeds for capped call transactions, common stock repurchases, debt repayment, and general corporate purposes. Tenable also expects to establish a new senior secured revolving credit facility and repurchase shares concurrently with the notes pricing.

IDEXX Laboratories Director Lawrence D. Kingsley sold 2,203 shares of stock worth $1.2 million on September 4, 2026, after exercising options. Despite the sale, Kingsley retains a significant stake of 9,568 shares valued at $5.12 million, indicating continued confidence in the company. The article notes that this exercise-and-sell transaction is typical for insiders and that IDEXX continues to demonstrate strong financial performance with double-digit growth in sales and EPS.

Jennifer Kong-Picarello, CFO of TEREX Corp, recently increased her holdings in the company to 87,838 shares after receiving an award of 21 shares. The award, valued at $61.15 per share, was granted on September 3, 2026. This transaction is categorized as an award or grant (code A) and reflects her updated total share ownership in TEREX CORP.

Chemours, DuPont de Nemours, and Corteva have agreed to a $455 million settlement with North Carolina and 11 communities regarding PFAS "forever chemicals" contamination. The settlement resolves litigation alleging leaks from Chemours' Fayetteville Works facility. Payments will be distributed over a 15-year period.